Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Agenus Inc. (AGEN)

2.83   0.06 (2.17%) 08-16 16:00
Open: 2.79 Pre. Close: 2.77
High: 2.84 Low: 2.745
Volume: 613,491 Market Cap: 389M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.843 - 2.854 2.854 - 2.863
Low: 2.712 - 2.725 2.725 - 2.736
Close: 2.81 - 2.831 2.831 - 2.847

Technical analysis

as of: 2019-08-16 4:45:44 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.32     One year: 3.87
Support: Support1: 2.40    Support2: 2.13
Resistance: Resistance1: 2.84    Resistance2: 3.32
Pivot: 2.52
Moving Average: MA(5): 2.75     MA(20): 2.49
MA(100): 2.71     MA(250): 2.59
MACD: MACD(12,26): 0.04     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 95.94     %D(3): 95.15
RSI: RSI(14): 61.38
52-week: High: 3.88  Low: 1.54  Change(%): 69.5
Average Vol(K): 3-Month: 96470  10-Days: 103023

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AGEN has closed below upper band by 11.1%. Bollinger Bands are 73.9% wider than normal. The large width of the bands suggest high volatility as compared to AGEN's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Sat, 10 Aug 2019 07:07:05 Z
Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript

Fri, 09 Aug 2019 17:12:20 Z
Agenus (AGEN) Q2 Earnings Miss Estimates, Revenues Beat

Thu, 08 Aug 2019 16:18:40 Z
Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates

Mon, 08 Jul 2019 15:19:04 Z
Agenus (AGEN) Upgraded to Buy: What Does It Mean for the Stock?

Wed, 26 Jun 2019 12:08:07 Z
Gilead Inks Deal With Carna Biosciences for Immuno-Oncology

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 113.28
Shares Float (M) 91.95
% Held by Insiders 24.18
% Held by Institutions 28.85
Shares Short (K) 11280
Shares Short P. Month (K)

Stock Financials

EPS -0.882
EPS Est. Current Year -1.130
EPS Est. Next Year -1.290
EPS Est. Next Quarter -0.270
Forward EPS -1.449
Book Value (p.s.) -1.440
PEG Ratio
Profit Margin -99.82
Operating Margin -65.97
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth -1.1
Gross Profit (p.s.) -0.775
Sales Per Share
EBITDA (p.s.) -0.612
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E -3.21
P/E Growth Ratio 0.02
P/BV -1.97
P/S 364298144.00

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2011-10-03
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.